Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;17(3):219-21.
doi: 10.4103/0973-1075.92339.

Hypofractionated radiotherapy as local hemostatic agent in advanced cancer

Malik Tariq Rasool  1 , Najmi Arshad Manzoor, Syed Arshad Mustafa, Lone Mohammad Maqbool, Fir Afroz
Affiliations

Hypofractionated radiotherapy as local hemostatic agent in advanced cancer

Malik Tariq Rasool et al. Indian J Palliat Care. 2011 Sep.

Abstract

Purpose: Tumor bleeding continues to remain a challenge in an oncological setting, and radiotherapy has been studied as a local hemostatic agent. We studied the role of local radiotherapy in controlling bleeding at our center.

Materials and methods: We reviewed 25 treated cases (cancer urinary bladder: 12, lung cancer: 5, cervical cancer: 4, uterine cancer: 1, rectal cancer: 2, schwanoma: 1) at our center from March 2008 to December 2010. All patients had either an advanced or recurrent disease. Radiotherapy schedule was either 20 Gray in 5 fractions or 15 Gray in 5 fractions and was delivered with Cobalt 60.

Results and conclusion: Of 25 patients, 22 (88%) responded, and there was complete cessation of bleeding. Both 15 Gray and 20 Gray dose schedule had equal efficacy. Treatment was well tolerated without any intermission. Radiotherapy is a safe and effective option in controlling tumor bleeding.

Keywords: Hemostasis; Hypofractionation; Radiotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Pereira J, Mancini I, Bruera E. The management of bleeding in patients with advanced cancer. In: Portenoy RK, Bruera E, editors. Topics in Palliative Care. Vol. 4. New York: Oxford University Press; 2000. pp. 163–83.
    1. Srinivasan V, Brown CH, Turner AG. A comparison of two radiotherapy regimens for the treatment of symptoms from advanced bladder cancer. Clin Oncol (R Coll Radiol) 1994;6:11–3. - PubMed
    1. Hoskin PJ. In: Radiotherapy in symptom management. 2nd ed. Macdonald N, Hanks GW, Macdonald N, editors. Oxford University Press: New York; 1998. pp. 278–80.
    1. Brundage MD, Bezjak A, Dixon P, Grimard L, Larochelle M, Warde P, et al. The role of palliative thoracic radiotherapy in non-small cell lung cancer. Can J Oncol. 1996;6(Suppl 1):25–32. - PubMed
    1. Biswal BM, Lal P, Rath GK, Mohanti BK. Hemostatic radiotherapy in carcinoma of the uterine cervix. Int J Gynaecol Obstet. 1995;50:281–5. - PubMed